Exelon

Israel Leads the Way in Medical Innovation with Rivastigmine (Exelon)

07 Apr: Israel Leads the Way in Medical Innovation with Rivastigmine (Exelon)

Israel has become known for its innovation and technology. The company currently has the highest numbers of startups per capita, according to research. As one the major players in the technical innovation, the company has been instrumental in taking medical research to another level. Of particular importance is its contribution to Alzheimer’s research. Recently, the country recognized Prof. Marta Weinstock-Rosin for her role in creating the first FDA-approved medication for treating Alzheimer’s in its earliest stages. Made in Israel, Rivastigmine (Excelon) and Progress An estimated 4 billion adults in the U.S. have been affected by Alzheimer’s disease. Rivastigmine (Exelon) is one of the most exciting developments in treating Alzheimer’s disease Israeli researchers have been awarded the prestigious Israel Prize for Medicine for…